SOUTH SAN FRANCISCO, Calif., October 11, 2022--(BUSINESS WIRE)--Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company harnessing the power of high-efficiency precision gene repair to develop therapies with the potential to treat or cure serious diseases, today announced that members of its leadership team will participate in the 50th Annual Sickle Cell Disease Association of America (SCDAA) National Convention, taking place virtually October 11-15. The Convention is being held in partnership with the Sickle Cell in Focus (SCiF) Conference, hosted by the National Heart, Lung, and Blood Institute and the University of West Indies.
"We are proud to participate in the SCDAA National Convention and join forces with the sickle cell community to discuss the numerous challenges faced by people living with sickle cell disease and the latest advances in treatment and care," said Josh Lehrer, M.D., chief executive officer at Graphite Bio. "Together, we are working to achieve our common goal of curing sickle cell disease, relieving suffering and improving the quality of life for those around the world who are affected by this serious genetic disorder."
Details of Graphite Bio’s participation include:
Session: Clinical Trial/Drug Development I Presenter: Weston Miller, M.D., vice president of clinical development Date/Time: Thursday, October 13, 12:00-1:10 p.m. ET
Special Session: Visions of Corporate Partners Presenter: Josh Lehrer, M.D., chief executive officer Date/Time: Friday, October 14, 12:15-1:10 p.m. ET
This year’s SCDAA National Convention will address the multifactorial aspects of sickle cell disease and foster the exchange of the latest scientific and clinical information related to the disease through innovative symposia, training seminars, interactive panel discussions and activities designed to educate, motivate and mobilize the sickle cell community. For more information, visit the Convention website.
About Graphite Bio Graphite Bio is a clinical-stage, next-generation gene editing company driven to discover and develop cures for a wide range of serious and life-threatening diseases. The company is pioneering a precision gene editing approach that has the potential to transform human health by achieving one of medicine’s most elusive goals: to precisely "find & replace" any gene in the genome. Graphite Bio’s UltraHDR™ gene editing platform takes CRISPR beyond cutting and harnesses the power of high-efficiency precision DNA repair, also known as homology directed repair (HDR), to precisely correct genetic mutations, replace entire disease-causing genes with functional genes or insert new genes into predetermined, safe locations. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, including Maria Grazia Roncarolo, M.D., and Matthew Porteus, M.D., Ph.D.
Learn more about Graphite Bio by visiting www.graphitebio.com and following the company on LinkedIn and Twitter.
Forward-Looking Statements Statements we make in this press release may include statements that are not historical facts and are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements may be identified by words such as "aims," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "intends," "may," "plans," "possible," "potential," "seeks," "will" and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact, including statements regarding our nula-cel (formerly GPH101) product candidate, its clinical and therapeutic potential, our plans to advance nula-cel in our Phase 1/2 CEDAR trial and the potential benefit and impact of participating in the SCDAA National Convention on our business or the advancement of sickle cell treatment, may be deemed to be forward-looking statements. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and are making this statement for purposes of complying with those safe harbor provisions.
Any forward-looking statements in this press release are based on Graphite Bio’s current views about our plans, intentions, expectations, strategies and prospects only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements, including the risk that we may encounter regulatory hurdles or delays, for example, in patient enrollment and dosing, and in the progress, conduct and completion of our Phase 1/2 CEDAR trial and our other planned clinical trials. These risks concerning Graphite Bio’s programs and operations are described in additional detail in our periodic filings with the SEC, including our most recently filed periodic report, and subsequent filings thereafter. Graphite Bio explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221011005363/en/
Investors: Stephanie Yao Graphite Bio ir@graphitebio.com Media: Sheryl Seapy Real Chemistry media@graphitebio.com
Firefly Aerospace is on a roll. At 3:01 a.m. ET on Oct. 1, Firefly successfully launched its FLTA002 "Alpha" rocket into orbit, deploying three satellites as its payload and claiming 100% mission success on its second attempt to reach orbit.
Australian researchers say they've grown brain cells in a lab that have learned to play the vintage video game Pong. What's more, the "mini-brain" created by scientists took a surprisingly short amount of time to understand the game and begin to improve. How is this possible, and what might it mean for the future of artificial intelligence? Read on to find out. 1 Is This The First Sentient Artificial Brain? BBC News reported that the "mini-brain" created by the researchers can sense and respond
Time to prove just how smart you are.View Entire Post ›
The far side looks a lot like the near side. NASA's Scientific Visualization Studio, CC BYLooking up at the silvery orb of the Moon, you might recognize familiar shadows and shapes on its face from one night to the next. You see the same view of the Moon our early ancestors did as it lighted their way after sundown. Only one side of the spherical Moon is ever visible from Earth – it wasn’t until 1959 when the Soviet Spacecraft Luna 3 orbited the Moon and sent pictures home that human beings were
Materials known as metal-organic frameworks hold promise for advances in healthcare, energy and other areas, researchers say.
Mars is increasingly in the viewfinder of planetary scientists, as NASA has made it a goal to send a manned mission to the red planet, sending rovers to its surface and developing technology to prepare for human exploration. The increased focus on Mars has led to some intriguing discoveries—most recently, that life might have existed on the planet before climate change ended it. That's the suggestion of a new study; read on to find out more. 1 Young Mars May Have Had Atmosphere Friendly to Life
The parts that are being considered for sale include a stake in the SIX Group, which runs the Zurich stock exchange, an 8.6% holding in Madrid-based tech company Allfunds, two specialist Swiss banks, Pfandbriefbank and Bank-Now and Swisscard, a joint venture with American Express, the newspaper added. "We will update on progress on our comprehensive strategy review when we announce our third-quarter earnings," Credit Suisse told Reuters in an emailed statement. The hotel could be worth 400 million Swiss francs, as reported by finance blog Inside Paradeplatz early this month.
(Bloomberg) -- Financial chaos in the UK is hitting the shores of Japan and roiling the $1 trillion dollar global market for collateralized loan obligations. Norinchukin Bank, once known as the CLO whale, has stopped buying new deals in the US and Europe for the foreseeable future because of volatility sparked by UK pension funds, according to people familiar with the matter, who asked not to be identified because they’re not authorized to speak publicly. The move is likely a pause rather than a
A new rally attempt is already struggling. Netflix and Tesla earnings loom. Shockwave is a stock to watch.
Future Fund Active ETF co-founder Gary Black recommends to Tesla's board how it should spend some of the electric-vehicle company's cash.
Answer: It sounds like you’re feeling stressed about money and questioning your decisions, so we asked financial advisers and money pros what you’re doing right and what you might want to change. “I would base your savings rate towards a home, and how much you can temporarily divert from the student loan debt towards a home, on how much you think the home will cost,” says Joe Favorito, certified financial planner at Landmark Wealth Management.
While virus-related hospitalizations remain distressingly high, the decline from peaks has boosted profits for UnitedHealth and other insurers.
(Bloomberg) -- Chinese stocks trimmed declines during afternoon trading as traders digested President Xi Jinping’s speech, which offered support for the tech sector but disappointed investors hoping for signs of a shift away from Covid Zero. The benchmark CSI 300 Index traded 0.1% lower as of 1:43 p.m. local time after sliding as much as 0.9% in the morning. A gauge of Chinese equities listed in Hong Kong fell 0.7%, having earlier slumped more than 2%. Read: Xi Defends Covid Zero Without Showing
Out of all the big banks, Bank of America has been the one that is expected to fare better in the current climate.
See: I’m a 57-year-old nurse with no retirement savings and I want to retire within seven years. Having $110,000 in retirement accounts is great, and you don’t want to have to start dwindling that down while also trying to manage a way to effectively pay down credit card debt and a mortgage. “I think she needs to take a hard look at her income and expenses,” said Tammy Wener, a financial adviser and co-founder of RW Financial Planning.
Citizens Financial Group plans to expand wealth management operations; M&T has a new local business banking leader; and other recent banking news.
(Bloomberg) -- Tokyo’s yen watchers continued to speculate whether Japan conducted a stealth intervention last week, zeroing in on the volatility seen after Thursday’s surprise US inflation data.By one estimate, authorities may have spent around 1 trillion yen ($6.7 billion) to support the currency, a figure gleaned from a larger-than-expected Bank of Japan daily current account deficit. That would be just over a third of the 2.84 trillion yen spent in September, when Japan stepped in to help pr
The U.S. Justice Department on Sunday moved to dismiss an antitrust indictment against two former Pilgrim's Pride Corp executives who were the remaining defendants in a conspiracy prosecution that has failed to secure any convictions. Federal prosecutors asked U.S. District Judge Daniel Domenico to dismiss the case against Jason McGuire, who was a former executive vice president of sales at Pilgrim's Pride, and Timothy Stiller, a former general manager. They and other defendants were charged in 2021 of fixing prices in the poultry industry.
China's central bank held its key policy rates steady on Monday, which may mean the same holding pattern for benchmark lending rates later this month. The People's Bank of China injected 500 billion yuan ($69.6 billion) of liquidity via its medium-term lending facility, according to an official statement on its website. The MLF carries an interest rate of 2.75%, unchanged from the last operation, and a tenure of one year.
Soaring interest rates and weak economic growth have dented Wood's young, 'disruptive' technology companies.